Related Experiment Video
Updated: Sep 27, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Uncoordinated regulation of mRNA expression of the three isoforms of transforming growth factor-beta in the mouse
J E Rundhaug1, J Park, S M Fischer
1The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville 78957, USA.
Abstract:
The mRNA expression and autoregulation of expression of the three isoforms of transforming growth factor-beta (TGFbeta) were examined in the mouse skin carcinogenesis model by northern analyses. We found that TGFbeta3 mRNA levels followed a pattern similar to those of TGFbeta1 during carcinogenesis: the levels were somewhat low in normal skin but became highly overexpressed in late-stage papillomas and squamous cell carcinomas (15- to 20-fold higher than in normal skin). On the other hand, the TGFbeta2 mRNA levels remained relatively low in all benign and malignant tumors, even though the levels were higher than the nearly undetectable levels in normal skin. In a squamous cell carcinoma cell line (CH72), stable transfection and expression of a mutated simian TGFbeta1 cDNA producing bioactive TGFbeta1 significantly downregulated (mean greater than ten-fold) TGFbeta2 mRNA levels and modestly downregulated (about twofold) murine TGFbeta1 expression but had no effect on TGFbeta3 mRNA. In contrast, treatment of all CH72 clones with exogenous TGFbeta1, TGFbeta2, or TGFbeta3 either had no effect or slightly downregulated TGFbeta1 mRNA, upregulated TGFbeta2 mRNA expression an average of twofold to threefold, and strongly upregulated (mean 13- to 27-fold) TGFbeta3 mRNA levels. TGFbeta treatment of primary cultures of mouse skin keratinocytes upregulated all three TGFbeta mRNA levels slightly to moderately (1.3- to 5-fold). Thus, although TGFbeta1 and TGFbeta3 mRNA expressions were apparently coordinately upregulated during mouse skin carcinogenesis, the three TGFbeta mRNAs were differentially regulated by stable transfection of active TGFbeta1 versus exogenous TGFbeta treatment in CH72 cells and by TGFbeta treatments of normal keratinocytes versus carcinoma CH72 cells.
Insights
Transforming growth factor-beta (TGFbeta) mRNA levels differ in skin cancer. TGFbeta1 and TGFbeta3 are upregulated in tumors, while TGFbeta2 is less affected, showing differential regulation in carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Transforming growth factor-beta (TGFbeta) signaling plays a complex role in cancer development.
- Understanding the differential expression and regulation of TGFbeta isoforms is crucial for cancer research.
Purpose of the Study:
- To investigate the mRNA expression patterns of TGFbeta1, TGFbeta2, and TGFbeta3 during mouse skin carcinogenesis.
- To examine the autoregulation of TGFbeta isoform expression in response to TGFbeta1 and exogenous TGFbeta treatments.
Main Methods:
- Northern blot analysis was used to quantify TGFbeta mRNA levels in normal skin, papillomas, and squamous cell carcinomas.
- Stable transfection of a mutated TGFbeta1 cDNA into a squamous cell carcinoma cell line (CH72).
- Treatment of CH72 cells and primary mouse skin keratinocytes with exogenous TGFbeta isoforms.
Main Results:
- TGFbeta1 and TGFbeta3 mRNA levels were significantly upregulated (15- to 20-fold) in late-stage skin tumors compared to normal skin.
- TGFbeta2 mRNA levels were only slightly elevated in tumors.
- Stable expression of active TGFbeta1 downregulated TGFbeta2 mRNA, while exogenous TGFbeta treatments upregulated TGFbeta2 and strongly upregulated TGFbeta3 mRNA.
Conclusions:
- TGFbeta1 and TGFbeta3 mRNA are coordinately upregulated during skin carcinogenesis, suggesting a linked role.
- Differential regulation of TGFbeta isoforms occurs in response to TGFbeta1 expression and exogenous TGFbeta stimulation.
- Distinct regulatory mechanisms govern TGFbeta isoform expression in normal keratinocytes versus carcinoma cells.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020